FDA Inspection 1067222 — CCRM Minneapolis
The FDA completed an inspection of CCRM Minneapolis on Aug 31, 2018 in Edina, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 31, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Edina, MN (United States)